Other studies also outlined JQ1 as a potential target for treating DIPG tumors with the Cyclin Dependent Kinase 7 (CDK7) inhibitor THZ1, targeting RNA Pol II phosphorylation [94, 95]. Here, CDK7 is linked to diffuse intrinsic pontine glioma.